Test Price
2,800 AED✅ Home Collection Available
ACO2 Gene Cerebellar-Retinal Degeneration, Infantile Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين ACO2 للتنكس المخيخي الشبكي الطفولي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation from DHA-licensed genetic counsellors.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي: يضمن اختبار تسلسل الحمض النووي الجيني لجين ACO2 باستخدام تقنية NGS دقة تشخيصية فائقة (حساسية 99.9٪)، مع خدمة سحب منزلي متميزة واستشارة ما بعد الفحص. التسعير 2800 درهم، مع التحقق المباشر من التأمين عبر الواتساب.
Test Overview & Competitive Comparison
The ACO2 Gene Cerebellar-Retinal Degeneration, Infantile Genetic Test diagnoses autosomal recessive infantile cerebellar-retinal degeneration by sequencing the entire coding region of the ACO2 gene. This test is essential for confirming clinical suspicion in infants with progressive cerebellar atrophy and retinal dystrophy, enabling early intervention and family counselling. يُجري الاختبار تسلسلاً شاملاً لجين ACO2 للكشف عن الطفرات المسببة للتنكس المخيخي الشبكي الطفولي.
| Feature | Our Test (DHA-Accredited) | Closest Alternative |
|---|---|---|
| Methodology | NGS (Next-Generation Sequencing) – full gene analysis | Single-gene Sanger or panel without ACO2 |
| Diagnostic Yield | >99% sensitivity for ACO2 mutations | Variable, often <80% if ACO2 not targeted |
| Turnaround Time | 3–4 Weeks | 4–8 Weeks |
Physician Insight & Pre-Test Safety Protocol
Dr. PRABHAKAR REDDY (DHA License: 61713011) notes:
"Infantile cerebellar-retinal degeneration due to ACO2 mutations is a severe, rapidly progressive disorder. A timely genetic diagnosis not only confirms the condition but also opens doors to reproductive planning and targeted supportive care. Always correlate results with clinical and neuroimaging findings."
Critical Medication Advisory
Do not discontinue any prescribed anticonvulsant, anti-spasticity, or vitamin supplementation without consulting your treating physician. Abrupt cessation may precipitate acute neurological deterioration.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Known interfering bone marrow transplant within last 90 days.
- Exclusion: Active hemolysis or blood transfusion within 2 weeks.
- ER Red Flag: If your child develops new-onset seizures, respiratory distress, or loss of swallowing after sample collection, proceed immediately to the nearest emergency department.
- ER Red Flag: Any signs of severe metabolic decompensation (vomiting, lethargy, hypoglycemia) require urgent medical evaluation.
Patient FAQ & Clinical Guidance
1. How accurate is the ACO2 gene test for infantile cerebellar-retinal degeneration?
Our NGS-based test achieves >99.9% analytical sensitivity for single nucleotide variants and small indels in the ACO2 gene. It detects mutations missed by outdated Sanger sequencing, providing a definitive molecular diagnosis in virtually all biochemically suspected cases.
ما مدى دقة اختبار جين ACO2؟ تصل حساسيته التحليلية إلى أكثر من 99.9% للطفرات النقطية، مما يضمن تشخيصاً نهائياً.
2. What does the require and how is the sample collected at home?
A single blood draw (3–5 mL in EDTA tube) is collected by a DHA-licensed pediatric phlebotomist during our ISO-certified cold-chain home visit. No fasting is needed, and the procedure respects UAE Ministry of Health guidelines for neonatal and infant handling.
ما هي متطلبات الاختبار؟ يتم سحب عينة دم واحدة عبر زيارة منزلية معتمدة من هيئة الصحة بدبي، دون الحاجة للصيام.
3. Can I interpret the results myself or use them for legal/immigration purposes?
Results are reported only through a board-certified clinical geneticist; self-interpretation is strongly discouraged due to complex genotype-phenotype correlations. For legal use, a Medico-Legal addendum is available, and we comply with Federal Decree-Law No. 41 of 2024 on genetic data confidentiality.
هل يمكنني تفسير النتائج بنفسي؟ لا، يجب أن يتم تفسيرها عبر أخصائي الوراثة الإكلينيكي؛ ونوفر تقريراً قانونياً معتمداً عند الطلب.
Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139)
Data Privacy: UAE PDPL & Federal Decree-Law No. 41 of 2024 (Art. 87) Compliant
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians